. Median (IQR) intra-patient TE, pSWE, APRI, FIB-4 and Fibrotest values changes at different time points relative in chronic HBV patients with at least two determinations of non-invasive methods over time.
Time Point
Patients TE (kPa) pSWE (m/s) APRI FIB-4 Fibrotest FU1 n = 255 −0.10 p = 0.82 0.00 p = 0.65 +0.01 p = 0.67 +0.05 p = 0.00 +0.01 p = 0.16 FU2 n = 156 −0.01 p = 0.88 −0.02 p = 0.62 −0.01 p = 0.82 −0.01 p = 0.01 −0.03 p = 0.26 FU3 n = 107 −0.06 p = 0.91 −0.01 p = 0.66 −0.01 p = 0.73 +0.05 p = 0.05 −0.02 p = 0.17 FU4 n = 71 −0.20 p = 0.72 0.00 p = 0.85 −0.01 p = 1.0 +0.02 p = 0.12 −0.03 p = 0.16 FU5 n = 30 −0.09 p = 0.77 −0.07 p = 0.09 −0.03 p = 0.03 +0.02 p = 0.22 +0.03 p = 0.00 FU6 n = 6 −0.51 p = 0.27 −0.04 p = 0.05 −0.05 p = 0.00 −0.04 p = 0.30 +0.01 p = 0.00 APRI, aspartate to platelet ratio index; FIB-4, fibrosis index based on four factors; FU, Follow up; pSWE, point shearwave elastography; TE, transient elastography.
